Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

Carvykti sales surge, MRD FDA guidance speeds label expansion, and strong cash runway. Click for more on LEGN stock.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific ...